Prospera Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
32,791
-5,774
-15% -$466K 0.04% 447
2026
Q1
$3.34M Buy
38,565
+4,323
+13% +$414K 0.05% 365
2025
Q4
$3.29M Sell
34,242
-3,122
-8% -$303K 0.05% 351
2025
Q3
$3.56M Sell
37,364
-6,895
-16% -$634K 0.06% 330
2025
Q2
$3.86M Sell
44,259
-20,475
-32% -$1.74M 0.07% 284
2025
Q1
$5.82M Sell
64,734
-2,321
-3% -$208K 0.13% 173
2024
Q4
$5.36M Buy
67,055
+2,852
+4% +$247K 0.12% 187
2024
Q3
$5.78M Sell
64,203
-856
-1% -$72K 0.15% 152
2024
Q2
$5.12M Sell
65,059
-364
-0.6% -$29.8K 0.14% 155
2024
Q1
$5.7M Sell
65,423
-21,426
-25% -$1.83M 0.17% 127
2023
Q4
$7.15M Sell
86,849
-162
-0.2% -$12.3K 0.24% 97
2023
Q3
$6.82M Sell
87,011
-2,850
-3% -$239K 0.26% 85
2023
Q2
$7.92M Buy
89,861
+9,724
+12% +$837K 0.3% 71
2023
Q1
$6.46M Buy
80,137
+23,608
+42% +$1.92M 0.27% 94
2022
Q4
$4.39M Sell
56,529
-24,631
-30% -$2M 0.22% 114
2022
Q3
$6.55M Buy
81,160
+4,420
+6% +$397K 0.34% 59
2022
Q2
$6.89M Buy
76,740
+7,617
+11% +$772K 0.35% 48
2022
Q1
$7.67M Buy
69,123
+7,424
+12% +$784K 0.32% 49
2021
Q4
$6.38M Buy
61,699
+5,546
+10% +$642K 0.28% 81
2021
Q3
$7.04M Sell
56,153
-6,056
-10% -$784K 0.35% 48
2021
Q2
$7.72M Buy
62,209
+2,576
+4% +$323K 0.39% 40
2021
Q1
$7.05M Buy
59,633
+1,540
+3% +$180K 0.42% 33
2020
Q4
$6.8M Buy
58,093
+41,491
+250% +$4.57M 0.47% 25
2020
Q3
$1.72M Sell
16,602
-41,292
-71% -$4.15M 0.66% 32
2020
Q2
$5.14M Sell
57,894
-3,206
-5% -$307K 0.46% 32
2020
Q1
$5.51M Buy
61,100
+1,633
+3% +$174K 0.58% 21
2019
Q4
$6.75M Buy
59,467
+30,089
+102% +$3.3M 0.52% 22
2019
Q3
$3.19M Sell
29,378
-329
-1% -$34.3K 0.33% 56
2019
Q2
$2.9M Sell
29,707
-47
-0.2% -$4.29K 0.33% 56
2019
Q1
$2.68M Buy
29,754
+8,213
+38% +$735K 0.88% 26
2018
Q4
$1.95M Buy
21,541
+16,842
+358% +$1.57M 0.39% 53
2018
Q3
$448K Sell
4,699
-3,011
-39% -$278K 0.08% 231
2018
Q2
$662K Sell
7,710
-270
-3% -$22.6K 0.09% 189
2018
Q1
$629K Sell
7,980
-138
-2% -$11.4K 0.09% 202
2017
Q4
$681K Buy
8,118
+8
+0.1% +$641 0.1% 168
2017
Q3
$637K Buy
8,110
+757
+10% +$62.8K 0.1% 192
2017
Q2
$643K Buy
7,353
+2,074
+39% +$175K 0.1% 183
2017
Q1
$425K Buy
5,279
+93
+2% +$7.26K 0.08% 216
2016
Q4
$369K Sell
5,186
-49
-0.9% -$3.85K 0.07% 235
2016
Q3
$452K Buy
5,235
+105
+2% +$9.15K 0.09% 198
2016
Q2
$445K Buy
5,130
+2,028
+65% +$164K 0.09% 188
2016
Q1
$233K Buy
+3,102
New +$234K 0.05% 267

Other funds holding MDT

Prospera Financial Services's MDT Position: Q2 2026 in Review

Prospera Financial Services reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $466K and leaving 32,791 shares worth $2.57M. The position accounts for 0.04% of the portfolio, ranked #447.

Prospera Financial Services first reported a position in MDT in Q1 2016 and has held it in 42 quarters since. The position peaked at $7.92M in Q2 2023. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Prospera Financial Services held 32,791 shares of Medtronic worth $2.57M as of Q2 2026.
  • Prospera Financial Services sold 5,774 Medtronic shares in Q2 2026, an estimated $466K.
  • Medtronic made up 0.04% of Prospera Financial Services's portfolio in Q2 2026, its #447 holding.
  • Prospera Financial Services first reported a position in Medtronic in Q1 2016 and has held it in 42 quarters since.
  • Prospera Financial Services's Medtronic position peaked at $7.92M in Q2 2023.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.